Revisiting the Cuban Healthcare Sector

Revisiting the Cuban Healthcare Sector

The death of longtime Cuban leader Fidel Castro is a potential watershed event for the economic course of the island nation. Diplomatic détente between Cuba and the United States was already underway earlier this year when Kalorama Information provided an overview of Cuban biopharmaceuticals, medical devices, and medical care. Through a combination of economic and healthcare policies prioritized under the Castro regime and the unrelenting pressure of globalization, Cuba may soon emerge as a significant player in global healthcare industries.


Cuban Biopharmaceuticals, Diagnostics and Medical Care Find Growing Interest from U.S. and International Healthcare Sectors

Cuban Biopharmaceuticals, Diagnostics and Medical Care Find Growing Interest from U.S. and International Healthcare Sectors

Remarkably, Cuba, despite near isolation from U.S. medical research, has managed notable advances in medical technology from its own industry. Cuban development of medical products such as cancer therapeutics , in vitro diagnostic (IVD) platforms and vaccines has occurred in the vacuum of U.S.-pioneered medical advances, but often manage only limited visibility internationally due to difficulties in investment. Reconciliation between the United States and Cuba has the potential to improve the di...


Broad-Based Growth Evident in Latin American IVD Market

Broad-Based Growth Evident in Latin American IVD Market

Brazil figures heavily into IVD strategies for the Latin American continent with a population of over 200 million people and industry to support globally distributed supply operations. However, the country’s regional economic clout does not necessarily ensure its status as a leading target expansion market for IVD companies. According to Kalorama Information’s latest projections for the Latin American IVD market , the less competitive IVD markets of Chile, Colombia and Peru are expected to grow ...